1. A phase II randomized, multicenter, open-label trial of continuing adjuvant temozolomide beyond 6 cycles in patients with glioblastoma (GEINO 14-01). Issue 12 (24th April 2020) Authors: Balana, Carmen; Vaz, Maria Angeles; Manuel Sepúlveda, Juan; Mesia, Carlos; del Barco, Sonia; Pineda, Estela; Muñoz-Langa, Jose; Estival, Anna; de las Peñas, Ramón; Fuster, Jose; Gironés, Regina; Navarro, Luis Miguel; Gil-Gil, Miguel; Alonso, Miriam; Herrero, Ana; Peralta, Sergio; Olier, Clara; Pe... Journal: Neuro-oncology Issue: Volume 22:Issue 12(2020) Page Start: 1851 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Cabazitaxel for metastatic castration-resistant prostate cancer: safety data from the Spanish expanded access program. (September 2014) Authors: Castellano, Daniel; Antón Aparicio, Luis M; Esteban, Emilio; Sánchez-Hernández, Alfredo; Germà, Jose Ramón; Batista, Norberto; Maroto, Pablo; Pérez-Valderrama, Begoña; Luque, Raquel; Méndez-Vidal, María José Journal: Expert opinion on drug safety Issue: Volume 13:Number 9(2014) Page Start: 1165 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. SNPs associated with activity and toxicity of cabazitaxel in patients with advanced urothelial cell carcinoma. (April 2016) Authors: Duran, Ignacio; Hagen, Carlos; Arranz, José Ángel; Apellaniz-Ruiz, María; Pérez-Valderrama, Begoña; Sala, Nuria; Lainez, Nuria; García-Del Muro, Xavier; Noguerón, Esther; Climent, Miguel Ángel; Maroto, Pablo; Font, Albert; García-Donas, Jesús; Gallardo, Enrique; López-Criado, Pilar; González Del ... Journal: Pharmacogenomics Issue: Volume 17:Number 5(2016) Page Start: 463 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗